
Park Medi World, a healthcare company operating Park Hospitals in North India, has announced the price band for its initial public offering (IPO) at ₹154 to ₹162 per share.
The offering will open for public subscription from December 10 and aims to raise ₹920 crore through a combination of new equity and offer for sale by an existing promoter.
The IPO consists of a fresh issue of 4.75 crore equity shares worth ₹770 crore and an offer for sale (OFS) of 93 lakh shares amounting to ₹150 crore by promoter Dr Ajit Gupta.
The share price band is set between ₹154 and ₹162, with a face value of ₹2 per equity share. At the upper end of the price band, the total size of the issue is ₹920 crore.
The subscription window opens on December 10 and closes on December 12. Anchor investors will be allowed to bid on December 9, a day before public bidding begins.
The basis of allotment will likely be finalised by December 15. Refunds will initiate on December 16, and shares will be credited to investors’ demat accounts by the same day. Park Medi World is expected to list on NSE and BSE on December 17.
Retail investors can apply for a minimum of 92 shares and in multiples thereafter. Out of the total issue, up to 50% is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and a minimum 35% for retail investors.
Read More: Private Equity Firm Gaja Capital Files Updated DRHP with SEBI for IPO, Plans to Raise ₹656 Crore!
Headquartered in North India, Park Medi World manages Park Hospitals with an aggregate bed capacity of 3,250 as of September 30, 2025.
The company is participating in a book-building process under SEBI regulations for this IPO. Dr Ajit Gupta, offering shares under OFS, acquired them at an average cost of ₹0.08 per share.
The IPO indicates a price-to-earnings (P/E) ratio of 27.75 to 29.19 times based on projected FY25 earnings. The floor price is 77 times and the cap price is 81 times the face value.
Park Medi World’s upcoming IPO with a price band of ₹154–₹162 aims to raise ₹920 crore through a mix of fresh issue and offer for sale. With a strong regional presence in healthcare, the company joins a growing list of healthcare firms tapping capital markets.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Dec 6, 2025, 11:35 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates